Epidural Abscess Treatment Market Size & Share, by Type (Intracranial, Intraspinal); Treatment (Antifungal Drugs, Antibiotics, Surgery); End-user (Hospital, Pharmacy, Specialty Clinics) - Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2023-2035

  • Report ID: 3437
  • Published Date: Apr 04, 2023
  • Report Format: PDF, PPT

Companies Dominating the Epidural Abscess Treatment Landscape

    • Alembic Limited
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Eli Lilly and Company
    • Sandoz Inc.
    • Sun Pharmaceutical Industries Limited
    • Novartis AG
    • Sanofi-aventis Groupe
    • Abbott Laboratories
    • Merck & Co., Inc.
    • Pfizer Inc.
    • Siemens Healthcare GmbH

Browse Key Market Insights with Data Illustration:


In The News

  • Sun Pharmaceutical Industries Limited has completed the acquisition of Concert Pharmaceuticals, Inc., which is a leading clinical biopharmaceutical company.

  • Sandoz Inc. introduced Ciprofloxacin 0.3% + Dexamethasone 0.1% otic suspension in the United States for the treatment of bacterial infections such as acute otitis media and acute otitis externa.

Author Credits:  Radhika Gupta, Shivam Bhutani

  • Report ID: 3437
  • Published Date: Apr 04, 2023
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

The surge in head surgeries, rising cases of otitis media, and increasing ratio of traumatic brain injury are the major factors driving the market growth.

The market size of epidural abscess treatment is anticipated to attain a CAGR of ~9% over the forecast period, i.e., 2023-2035.

Difficult diagnosis of abscess, high cost of surgical treatment of epidural abscess, and lack of awareness regarding the epidural abscess in emerging nations are estimated to be the growth hindering factors for the market expansion.

The market in the North American region is projected to hold the largest market share by the end of 2035 and provide more business opportunities in the future.

The major players in the market are Alembic Limited, Eli Lilly and Company, Sandoz Inc., Sun Pharmaceutical Industries Limited, Novartis AG, Sanofi-aventis Groupe, Abbott Laboratories, Merck & Co., Inc., Pfizer Inc., and others.

The company profiles are selected based on the revenues generated from the product segment, geographical presence of the company which determine the revenue generating capacity as well as the new products being launched into the market by the company.

The market is segmented by type, treatment, end-user, and by region.

The hospital segment is anticipated to garner the largest market size by the end of 2035 and display significant growth opportunities.
Inquiry Before Buying Request Free Sample

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying